Trisequens

Medicinal product

(Invented) name

Trisequens

Active substance (s)

Estradiolis+Estradiolis/Noretisterono acetatas+Estradiolis

Strength

2 mg + 2 mg/1 mg + 1 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03FB05, Norethisterone and estrogen

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2018-07-05

Date of renewal

Documents

0690_Trisequens_2022-02-18.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Mėlynoje tabletėje yra	1 vnt.
Estradiolis	2 mg
Baltoje tabletėje yra	1 vnt.
Estradiolis	2 mg
Noretisterono acetatas	1 mg
Raudonoje tabletėje yra	1 vnt.
Estradiolis	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
99731	85839	1085839	tablečių talpyklė	N28 (N12 + N10 + N6)		Receptinis	LT/L/18/0690/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2018-07-05	Registruotas